DrugInformer Search

Endotracheal Intubation : Succinylcholine Chloride Vs. Rocuronium Bromide


Tracheal intubation (usually simply referred to as intubation) is the placement of a flexible plastic catheter into the trachea. This invasive medical procedure is frequently performed in critically injured, ill or anesthetized patients in order to facilitate positive pressure ventilation of the lungs, including mechanical ventilation, and to prevent the possibility of pulmonary aspiration or airway obstruction. The most widely used route for tracheal intubation is orotracheal, in which an endotracheal tube is passed through the oropharynx, glottis and larynx into the trachea. Another route for tracheal intubation is nasotracheal, in which an endotracheal tube is passed through the nasopharynx, glottis and larynx into the trachea. Other routes for intubation of the trachea include the cricothyrotomy (used almost exclusively in emergency circumstances) and the tracheotomy (used primarily in circumstances where a prolonged need for airway support is anticipated).

Read more on Wikipedia

Compare Drugs

Please add a drug to the list to compare them side by side.
Add a new Drug

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.